| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药流通(元) | 13,710,088.40 | 17,147,437.40 | 7,126,712.56 | 13,303,561.40 | 8,296,426.20 |
| 医药制造(元) | 200,871,164.15 | 455,981,262.52 | 210,060,473.65 | 515,600,619.59 | 258,107,272.72 |
| 营业成本(元) | |||||
| 医药流通(元) | 10,828,452.52 | 14,743,287.18 | 6,970,329.08 | 12,520,993.02 | 7,957,287.39 |
| 医药制造(元) | 95,522,585.09 | 220,648,294.64 | 101,937,738.95 | 268,052,549.37 | 138,848,433.75 |
| 毛利(元) | |||||
| 医药流通(元) | 2,881,635.88 | 2,404,150.22 | 156,383.48 | 782,568.38 | 339,138.81 |
| 医药制造(元) | 105,348,579.06 | 235,332,967.88 | 108,122,734.70 | 247,548,070.22 | 119,258,838.97 |
| 毛利率(%) | |||||
| 医药流通(%) | 21.02 | 14.02 | 2.19 | 5.88 | 4.09 |
| 医药制造(%) | 52.45 | 51.61 | 51.47 | 48.01 | 46.21 |
| 收入构成(%) | |||||
| 医药流通(%) | 6.39 | 3.62 | 3.28 | 2.52 | 3.11 |
| 医药制造(%) | 93.61 | 96.38 | 96.72 | 97.48 | 96.89 |
| 毛利构成(%) | |||||
| 医药流通(%) | 2.66 | 1.01 | 0.14 | 0.32 | 0.28 |
| 医药制造(%) | 97.34 | 98.99 | 99.86 | 99.68 | 99.72 |